These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Does HIV-2 protect against HIV-1 infection? Aaby P; Poulsen AG; Larsen O; Christiansen CB; Jensen H; Melbye M; Nauclér A; Dias F AIDS; 1997 Jun; 11(7):939-40. PubMed ID: 9189228 [No Abstract] [Full Text] [Related]
3. Seroprevalence of HIV among male prisoners in Lagos State, Nigeria. Dada MO; Akanmu AS; Esan OA Niger Postgrad Med J; 2006 Mar; 13(1):6-9. PubMed ID: 16633370 [TBL] [Abstract][Full Text] [Related]
4. Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype. Sarr AD; Sankalé JL; Hamel DJ; Travers KU; Guèye-Ndiaye A; Essex M; Mboup S; Kanki PJ Virology; 2000 Mar; 268(2):402-10. PubMed ID: 10704348 [TBL] [Abstract][Full Text] [Related]
5. Does HIV-2 infection provide cross-protection against HIV-1 infection? Ariyoshi K; Schim van der Loeff M; Sabally S; Cham F; Corrah T; Whittle H AIDS; 1997 Jul; 11(8):1053-4. PubMed ID: 9223741 [No Abstract] [Full Text] [Related]
6. [Four year management of HIV serology at the National Center of Blood Transfusion in Conakry]. Loua A; Magassouba FB; Camara M; Haba NG; Balde AM Bull Soc Pathol Exot; 2004 May; 97(2):139-41. PubMed ID: 15255362 [TBL] [Abstract][Full Text] [Related]
7. A primer on HIV/AIDS. JCN J Christ Nurs; 2007; 24(1):14-6; quiz 17-8. PubMed ID: 17283817 [No Abstract] [Full Text] [Related]
8. Evaluation of the Murex HIV Ag/Ab Combination assay when used with dried blood spots. Lakshmi V; Sudha T; Bhanurekha M; Dandona L Clin Microbiol Infect; 2007 Nov; 13(11):1134-6. PubMed ID: 17725648 [TBL] [Abstract][Full Text] [Related]
9. Clinical manifestation of HIV infection in northern Zaire. Strecker W; Gürtler L; Binibangili M; Strecker K AIDS; 1993 Apr; 7(4):597-8. PubMed ID: 8507428 [No Abstract] [Full Text] [Related]
12. [Evolution of HIV virus]. Salminen M; Leinikki P Duodecim; 1996; 112(2):130-4. PubMed ID: 10590619 [No Abstract] [Full Text] [Related]
13. Seroprevalence of HIV infection in patients with history of multiple blood transfusions. Jindal N; Aggarwal A Indian J Pathol Microbiol; 2006 Oct; 49(4):633-4. PubMed ID: 17183884 [No Abstract] [Full Text] [Related]
14. HIV/AIDS in the Eastern Mediterranean: a false immunity? Kim JY East Mediterr Health J; 2002 Nov; 8(6):684-8. PubMed ID: 15568444 [No Abstract] [Full Text] [Related]
16. Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established? Goujard C; Chaix ML; Lambotte O; Deveau C; Sinet M; Guergnon J; Courgnaud V; Rouzioux C; Delfraissy JF; Venet A; Meyer L; Clin Infect Dis; 2009 Sep; 49(6):982-6. PubMed ID: 19681706 [TBL] [Abstract][Full Text] [Related]
17. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Migueles SA; Laborico AC; Shupert WL; Sabbaghian MS; Rabin R; Hallahan CW; Van Baarle D; Kostense S; Miedema F; McLaughlin M; Ehler L; Metcalf J; Liu S; Connors M Nat Immunol; 2002 Nov; 3(11):1061-8. PubMed ID: 12368910 [TBL] [Abstract][Full Text] [Related]
18. HIV-1 and HIV-2 seropositivity among female sex workers in the Tenere Desert, Niger. Gragnic G; Julvez J; Abari A; Alexandre Y Trans R Soc Trop Med Hyg; 1998; 92(1):29. PubMed ID: 9692142 [No Abstract] [Full Text] [Related]
19. Seroprevalence of human immunodeficiency virus-2 in and around Amritsar. Arora U; Jindal N; Chopra S Indian J Pathol Microbiol; 2007 Oct; 50(4):926-7. PubMed ID: 18306608 [TBL] [Abstract][Full Text] [Related]
20. Challenges in the development of an effective HIV vaccine: current approaches and future directions. Klein E; Ho RJ Clin Ther; 2000 Mar; 22(3):295-314; discussion 265. PubMed ID: 10963285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]